Novartis (NVS)
(Delayed Data from NYSE)
$115.30 USD
+1.56 (1.37%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $115.07 -0.23 (-0.20%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth A Momentum A VGM
Fundamental Charts
About Market Cap
As of the previous market close, Novartis AG has a market cap of $240.27B, which represents its share price of $113.74 multiplied by its outstanding shares number of 2.11B. As a large-cap company, NVS's shareholders are generally exposed to less risk than shareholders of small and mid-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
NVS 115.30 +1.56(1.37%)
Will NVS be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for NVS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for NVS
ALNY Q2 Earnings Top Estimates on Higher Amvuttra Revenues, Stock Up
Ionis Beats on Q2 Earnings & Sales, Stock Up 5% on Raised '25 Outlook
NVS: What are Zacks experts saying now?
Zacks Private Portfolio Services
INCY's Q2 Earnings & Revenues Beat Estimates on Higher Product Sales
Incyte Gears Up to Report Q2 Earnings: Is a Beat in the Cards?
Here's Why Novartis (NVS) is a Strong Value Stock
Other News for NVS
Notable healthcare headlines for the week: Trump’s ultimatum to big pharma, Novo Nordisk, UnitedHealth and Moderna in focus
Market Voices: Trump vs. Big Pharma, Swiss tariffs, tariff legality
Private Markets: Scale rival Surge AI in talks for funding at $25B value
Trump Trade: Trump signs executive order raising tariff on Canada to 35%
Market Today: Amazon (AMZN) and Apple (AAPL) Lead Earnings Surge